Back to search

Sweden· SE-20160130000166

Vemlidy 25 mg Filmdragerad tablett

A medicinal product containing tenofovir alafenamide, registered in Sweden by Gilead Sciences Ireland UC.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedVemlidy 25 mg Filmdragerad tablettATC—REGISTER NO.SE-20160130000166PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Tenofovir Alafenamide
Manufacturer
Gilead Sciences Ireland UC
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20160130000166

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tenofovir alafenamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir alafenamide products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Tenofoviralafenamid Devatis
  • Iceland · Vemlidy
  • Liechtenstein · Vemlidy
  • Netherlands · Tenofoviralafenamide Devatis
  • Norway · Vemlidy
  • Portugal · Tenofovir Alafenamida Humanis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8729b23-acfb-4922-b4a0-8a84d47c5bf4
GET /v1/drugs/d8729b23-acfb-4922-b4a0-8a84d47c5bf4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20160130000166",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20160130000166",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/vemlidy-epar-product-information_sv.pdf"
}

See everything about tenofovir alafenamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.